NFKB1 and diabetic kidney disease: In advanced DKD stages characterized by severe oxidative stress and heme oxidation, cGMP-independent mechanisms—such as suppression of NF-κB-mediated inflammation or direct inhibition of TGF-β/Smad3 fibrotic signaling—may become clinically relevant [25,34].